Samuel Bakhoum, Founder, Board Member and Chief Scientific Officer at Volastra Therapeutics shared a post by The Mark Foundation for Cancer Research on X, adding:
“Thank you The Mark Foundation for Cancer Research for the kind words and for the support. Thrilled to join the physician scientist community at ASCI.”
Quoting The Mark Foundation for Cancer Research‘s post:
Our Emerging Leader Award winners are superstars – and two of them were just elected to ASCI!
Congratulations, Samuel Bakhoum and Mario Suva.”
Other articles about ASCI on OncoDaily.